EDWARD MCKEITHAN: Open Payments
NPI 1821295668 · BOLIVIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 46 payments from 15 companies in 2025. Trend: 2023 $1,058 · 2024 $1,488 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $396 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $331 |
| Lilly USA, LLC | 9 | $264 |
| Novo Nordisk Inc | 2 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81 |
| ANI Pharmaceuticals, Inc. | 3 | $65 |
| Braeburn Inc. | 2 | $35 |
| Amgen Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
Products named: CAPLYTA, FARXIGA, BREZTRI, Wegovy, ZEPBOUND, MOUNJARO, JARDIANCE, PURIFIED CORTROPHIN GEL.
Industry payments across NC — which companies pay providers there.
